Furthermore, the decrease in hepatic GLUT1 in the HSu-treated rats might be mediated by the hyperinsulinemia observed in this animal model [35], although supplementary confirmation of this hypothesis could be achieved by evaluating GLUT1 expression under fasting conditions. The gene discussed is SLC2A1; the disease is Hyperinsulinemia.